The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

OncoImmunology

Topics

Biology

Biochemistry

Cancer Oncology

Immunology

Cancer Research

Show all topics

DOI

10.1080/2162402x.2016.1263412

Other Formats

PDF